Laurus Labs Ltd. (LAURUSLABS): Laurus Labs Share Price Near 52-Week High as Stock Trades Higher
- September 17, 2026
- Posted by: Harsh Piplani
- Category: News
Laurus Labs Share Price is Rs 1,955.4, up 2.59% from the previous close, and is trading near its 52-week high as of 17 September 2026 at 12:22 PM IST. The company’s market capitalisation stands at Rs 1,03,902.04 Cr, placing today’s move in a large valuation context without changing the core event: the stock is trading close to its yearly high, not at a record high. For readers tracking Laurus Labs Share Price Today, the latest Univest data shows a session that opened at Rs 1,891.3, touched Rs 1,957.5 and stayed above the previous close through midday. That makes Laurus Labs Stock News relevant for investors looking at price action, valuation and sector comparison together.
What stands out in Laurus Labs Share Price Today is the combination of a firm intraday rise and proximity to a 52-week peak. The stock has added Rs 49.4 from the previous close of Rs 1,906, while turnover stands at Rs 7.14 Cr. The move is notable because the latest Univest figures confirm the price event, but they do not establish a company-specific catalyst. In other words, Laurus Labs Share Price is attracting attention because it is near a one-year high and because its valuation metrics, earnings metrics and healthcare-sector positioning are all visible in the same update.
Laurus Labs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,955.4 |
| Previous Close | Rs 1,906 |
| Today's Move | +Rs 49.4 (+2.59%) |
| Open | Rs 1,891.3 |
| High | Rs 1,957.5 |
| Low | Rs 1,891.3 |
| Turnover | Rs 7.14 crore |
| Market Capitalisation | Rs 1,03,902.04 crore |
Laurus Labs Ltd. (LAURUSLABS) traded at Rs 1,955.4 versus the previous close of Rs 1,906, a rise of 2.59%. The stock opened at Rs 1,891.3, reached a high of Rs 1,957.5 and touched a low of Rs 1,891.3.
Laurus Labs Share Price Today reflects a steady morning move rather than a sharp gap-and-hold pattern. The stock opened at Rs 1,891.3, matched that level as the day’s low, and later touched Rs 1,957.5, which leaves it just below the current quoted price of Rs 1,955.4. Against the previous close of Rs 1,906, the stock is higher by Rs 49.4 or 2.59%. Turnover at Rs 7.14 Cr gives a factual read on the day’s traded value, while the market cap remains Rs 1,03,902.04 Cr. For Laurus Labs Share Price readers, the key point is simple: the stock is trading close to its 52-week high and is being watched in the context of a strong daily move.
That makes Laurus Labs Share Price a stock news item for both short-term market tracking and longer-horizon research. The move also keeps Laurus Labs Share Price Today relevant for investors comparing the current price with the company’s broader one-year high zone and its current market capitalisation.
Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,03,902.04 crore |
| P/E Ratio | 94.19x |
| P/B Ratio | 18.26x |
| ROE | 18.31% |
| ROCE | 18.2% |
| EPS | Rs 20.24 |
| Book Value Per Share | Rs 104.37 |
| Dividend Yield | 0.1% |
Laurus Labs Ltd. (LAURUSLABS) fundamental metrics show P/E 94.19x, P/B 18.26x, ROE 18.31%, ROCE 18.2%. These figures provide context only and are not a buy or sell signal.
Laurus Labs Ltd. has a market capitalisation of Rs 103902.04 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 94.19x, P/B at 18.26x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.24, book value per share of Rs 104.37, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.1x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 94.19x |
| Benchmark Median P/E | 28.1x |
| Benchmark Average P/E | 40.13x |
| Benchmark P/E Range | 0x to 661.74x |
| Company P/B Ratio | 18.26x |
| Benchmark Median P/B | 2.92x |
| Company ROE | 18.31% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 18.2% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 1,03,902.04 crore |
| Benchmark Median Market Cap | Rs 730.86 crore |
Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 94.19x, which is above the benchmark median of 28.1x, a difference of +235.2%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Laurus Labs Ltd. (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 11.7%, a difference of +56.5%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 13.61%, a difference of +33.73%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,09,625.67 | 24.42 | 4.09 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,09,949.53 | 32.59 | 3.12 | 11.83 | 16 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 95,967.37 | 29.67 | 2.5 | 11.69 | 13.75 |
| Aurobindo Pharma Ltd. | AUROPHARMA | 95,794.67 | 25.43 | 2.43 | 9.93 | 12.76 |
| Mankind Pharma Ltd. | MANKIND | 94,531.56 | 45.46 | 5.52 | 12.69 | 13.24 |
Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 94.19x compared with the displayed peer median of 29.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.31% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 1,03,902.04 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Laurus Labs
- Laurus Labs Share Price is trading at Rs 1,955.4, up 2.59% from the previous close.
- The stock is near its 52-week high, keeping Laurus Labs Share Price Today in focus.
- Market capitalisation stands at Rs 1,03,902.04 Cr for Laurus Labs Share Price.
- P/E is 94.19 and P/B is 18.26, both above the same-industry medians.
- ROE is 18.31% and ROCE is 18.2%, which are above the sector medians in the benchmark.
About Laurus Labs
Laurus Labs Ltd. operates in Healthcare and is classified in Pharmaceuticals & Drugs. Laurus Labs Share Price is therefore followed not only as a market update but also as part of a broader pharmaceutical sector watchlist. The company’s reported figures include market capitalisation, earnings per share, book value and return ratios, which together shape Laurus Labs Stock Analysis in a factual way. For readers searching Laurus Labs Company News or Laurus Labs Latest News, the core company profile is centered on its sector and industry classification as reflected in the latest Univest data.
Frequently Asked Questions
Why is Laurus Labs Share Price in the news today?
Ans. Laurus Labs Share Price is in focus because it is trading at Rs 1,955.4, up 2.59%, and remains near its 52-week high. The market capitalisation is Rs 1,03,902.04 Cr.
What is Laurus Labs Share Price Today?
Ans. Laurus Labs Share Price Today is Rs 1,955.4. It is Rs 49.4 above the previous close of Rs 1,906, and the intraday high touched Rs 1,957.5 during the latest update.
How far is Laurus Labs Share Price from its yearly high?
Ans. Laurus Labs Share Price is trading near its 52-week high, which is the main event being tracked. The current level of Rs 1,955.4 keeps the stock in a one-year-high zone.
What does the Laurus Labs market capitalisation show?
Ans. Laurus Labs has a market capitalisation of Rs 1,03,902.04 Cr. That places Laurus Labs Share Price in a large valuation bracket within the healthcare and pharmaceuticals space. The company operates in the Healthcare sector.
What are the key valuation ratios for Laurus Labs Share Price?
Ans. Laurus Labs trades at a P/E of 94.19 and a P/B of 18.26. Both are higher than the same-industry medians in the benchmark, which is why Laurus Labs Share Price draws valuation scrutiny.
How do Laurus Labs ROE and ROCE look?
Ans. ROE is 18.31% and ROCE is 18.2% for Laurus Labs. Both figures stand above the sector medians listed in the benchmark, adding return context to Laurus Labs Share Price.
What are Laurus Labs EPS and book value?
Ans. EPS is Rs 20.24 and book value is Rs 104.37. These two figures help explain the earnings and accounting base behind Laurus Labs Share Price in the latest update.
Does Laurus Labs pay a dividend?
Ans. Laurus Labs has a dividend yield of 0.1%. For Laurus Labs Share Price readers, that is a factual income metric, while the main market focus today remains the near 52-week high.
Track Laurus Labs Share Price on Univest
Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Laurus Labs Share Price on Univest for live price movement, Laurus Labs Stock News, Laurus Labs Share Price Live updates, market capitalisation, valuation ratios, 52-week levels, sector context and peer comparison. Univest also surfaces Laurus Labs Fundamental Analysis and Laurus Labs Share Price Today in one place, making it easier to follow the stock as new market information comes in.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
